PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+12.89%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.25B
AUM Growth
+$2.25B
(+11%)
Cap. Flow
+$16M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
73.64%
Holding
48
New
2
Increased
21
Reduced
3
Closed
3
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$24.5M |
| 2 |
Karyopharm Therapeutics
KPTI
|
$21.2M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$17.7M |
| 4 |
Insmed
INSM
|
$2.06M |
| 5 |
United Therapeutics
UTHR
|
$1.74M |
Top Sells
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$27.4M |
| 2 |
Align Technology
ALGN
|
$16M |
| 3 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$12.1M |
| 4 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
$6.96M |
| 5 |
QLTI
QLT Inc
QLTI
|
$1.24M |
Sector Composition
| 1 | Healthcare | 69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $250M | 11.14% | 1,439,928 +10,000 | +0.7% | +$1.74M |
|
|
ANAC
2
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $240M | 10.68% | 3,103,027 -156,018 | -5% | -$12.1M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $227M | 10.1% | 1,660,092 +10,300 | +0.6% | +$1.41M |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $211M | 9.38% | 2,401,117 +279,260 | +13% | +$24.5M |
|
|
ABMD
5
DELISTED
Abiomed Inc
ABMD
| $180M | 8.01% | 2,742,305 +268,681 | +11% | +$17.7M |
|
|
AMAG
6
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $151M | 6.73% | 2,192,141 +5,100 | +0.2% | +$352K |
|
|
7
Insmed
INSM
$28.8B
| $116M | 5.14% | 4,733,601 +84,153 | +2% | +$2.06M |
|
|
THOR
8
DELISTED
THORATEC CORPORATION
THOR
| $114M | 5.07% | 2,560,303 +22,100 | +0.9% | +$985K |
|
|
KYTH
9
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $97.2M | 4.32% | 1,290,292 -92,430 | -7% | -$6.96M |
|
|
ENDP
10
DELISTED
Endo International plc
ENDP
| $68.9M | 3.06% | 864,604 +4,400 | +0.5% | +$350K |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $54M | 2.4% | 2,056,251 +7,000 | +0.3% | +$184K |
|
12
Vanda Pharmaceuticals
VNDA
$279M
| $49.5M | 2.2% | 3,897,408 +94,000 | +2% | +$1.19M |
|
|
13
Karyopharm Therapeutics
KPTI
$61.7M
| $47.1M | 2.09% | 1,731,530 +780,498 | +82% | +$21.2M |
|
14
Prothena Corp
PRTA
$441M
| $36.7M | 1.63% | 695,918 | – | – |
|
15
Gilead Sciences
GILD
$140B
| $35.1M | 1.56% | 299,500 +8,500 | +3% | +$995K |
|
|
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $33.2M | 1.48% | 1,455,176 | – | – |
|
|
SQNM
17
DELISTED
SEQUENOM INC NEW
SQNM
| $30.5M | 1.35% | 10,023,842 +46,200 | +0.5% | +$140K |
|
|
CELG
18
DELISTED
Celgene Corp
CELG
| $30.3M | 1.35% | 262,200 +12,800 | +5% | +$1.48M |
|
19
Amicus Therapeutics
FOLD
$2.34B
| $27.9M | 1.24% | 1,974,376 +18,000 | +0.9% | +$255K |
|
20
STAAR Surgical
STAA
$1.36B
| $25.5M | 1.14% | 2,642,922 | – | – |
|
|
CYBX
21
DELISTED
CYBERONICS INC
CYBX
| $24.5M | 1.09% | 412,000 | – | – |
|
|
SHPG
22
DELISTED
Shire pic
SHPG
| $23.7M | 1.06% | 98,300 +3,300 | +3% | +$797K |
|
|
MDVN
23
DELISTED
MEDIVATION, INC.
MDVN
| $20.6M | 0.92% | 180,300 +8,600 | +5% | +$982K |
|
|
ARIA
24
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $18.5M | 0.82% | 2,231,717 | – | – |
|
|
HTWR
25
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $17.7M | 0.79% | 243,868 | – | – |
|